KALEYDE PHARMACEUTICALS AG has a total of 22 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2007. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are NELSON PETER JON, GRUPO EMPRESARIAL DE PRODUCCIONES BIOFARMACEUTICAS Y QUIMICAS and BIRDIE BIOPHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Hong Kong | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | United States | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | South Africa | 2 | |
#11 | Montenegro | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | De Rosa Mario | 18 |
#2 | Mario De Rosa | 2 |
#3 | Carriero Maria Vincenza | 2 |
#4 | Pavone Vincenzo | 2 |
Publication | Filing date | Title |
---|---|---|
CN108463237A | Pharmaceutical preparation and its purposes for treating retinitis pigmentosa | |
CN108463238A | Pharmaceutical preparation for treating diabetes | |
AU2007283150A1 | Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |